Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

[up] Up a level
Number of items: 13.

Baldwin, Alex G. ORCID: https://orcid.org/0000-0002-7126-5220, Foley, David W. ORCID: https://orcid.org/0000-0001-8449-4754, Collins, Ross, Lee, Hyunah, Jones, D. Heulyn, Wahab, Ben, Waters, Loren, Pedder, Josephine, Paine, Marie, Feng, Gui Jie, Privitera, Lucia, Ashall-Kelly, Alexander, Thomas, Carys, Gillespie, Jason A., Schino, Lauramariú, Belelli, Delia, Rocha, Cecilia, Maussion, Gilles, Krahn, Andrea I., Durcan, Thomas M., Elkins, Jonathan M., Lambert, Jeremy J., Atack, John R. ORCID: https://orcid.org/0000-0002-3410-791X and Ward, Simon E. ORCID: https://orcid.org/0000-0002-8745-8377 2025. Discovery of MDI-114215: A potent and selective LIMK inhibitor to treat fragile X syndrome. Journal of Medicinal Chemistry 68 (1) , pp. 719-752. 10.1021/acs.jmedchem.4c02694
file

Baldwin, Alex ORCID: https://orcid.org/0000-0002-7126-5220, Foley, David, Collins, Ross, Lee, Hyunah, Jones, D. Heulyn, Wahab, Ben, Waters, Loren, Pedder, Josephine, Paine, Marie, Feng, Gui, Privitera, Lucia, Ashall-Kelly, Alexander, Thomas, Carys, Gillespie, Jason, Schino, Lauramariu, Belelli, Delia, Rocha, Cecilia, Maussion, Gilles, Krahn, Andrea, Durcan, Thomas, Elkins, Jonathan, Lambert, Jeremy, Atack, John ORCID: https://orcid.org/0000-0002-3410-791X and Ward, Simon ORCID: https://orcid.org/0000-0002-8745-8377 2025. Discovery of MDI-114215: A potent and selective LIMK inhibitor to treat Fragile X Syndrome. Journal of Medicinal Chemistry 68 (1) , pp. 719-752. 10.1021/acs.jmedchem.4c02694
file

University College Cardiff Consultants Limited 2022. Heteroaryl compounds useful in the treatment of cognitive disorders. WO2022/234271. [Patent].
file

Collins, Ross, Lee, Hyunah, Jones, Dyfyr, Elkins, Jonathan M., Gillespie, Jason A., Thomas, Carys, Baldwin, Alex G. ORCID: https://orcid.org/0000-0002-7126-5220, Jones, Kimberley, Waters, Loren, Paine, Marie, Atack, John R. ORCID: https://orcid.org/0000-0002-3410-791X, Ward, Simon E. ORCID: https://orcid.org/0000-0002-8745-8377, Grubisha, Olivera ORCID: https://orcid.org/0000-0003-1067-1230 and Foley, David W. ORCID: https://orcid.org/0000-0001-8449-4754 2022. Comparative analysis of small-molecule limk1/2 inhibitors: chemical synthesis, biochemistry, and cellular activity. Journal of Medicinal Chemistry 10.1021/acs.jmedchem.2c00751
file

University of Manchester 2020. Cyclic diarylboron derivatives as NLRP3 inflammasome inhibitors. US 10570157. [Patent].
file

Alnabulsi, Soraya, Hussein, Buthaina, Santina, Elham, Alsalahat, Izzeddin, Kadirvel, Manikandan, Magwaza, Rachael N., Bryce, Richard A., Schwalbe, Carl H., Baldwin, Alex ORCID: https://orcid.org/0000-0002-7126-5220, Russo, Ilaria, Stratford, Ian J. and Freeman, Sally 2018. Evaluation of analogues of furan-amidines as inhibitors of NQO2. Biorganic and Medicinal Chemistry Letters 28 (8) , pp. 1292-1297. 10.1016/j.bmcl.2018.03.025
file

Redondo-Castro, Elena, Faust, Dorte, Fox, Simon, Baldwin, Alex G. ORCID: https://orcid.org/0000-0002-7126-5220, Osborne, Simon, Haley, Michael J., Karran, Eric, Nuthall, Hugh, Atkinson, Peter J., Dawson, Lee A., Routledge, Carol, Allan, Stuart M., Freeman, Sally, Brownlees, Janet and Brough, David 2018. Development of a characterised tool kit for the interrogation of NLRP3 inflammasome-dependent responses. Scientific Reports 8 (1) , 5667. 10.1038/s41598-018-24029-3
file

Baldwin, Alex ORCID: https://orcid.org/0000-0002-7126-5220, Bevan, Jonathan, Brough, David, Ledder, Ruth and Freeman, Sally 2018. Synthesis and antibacterial activities of enamine derivatives of dehydroacetic acid. Medicinal Chemistry Research 27 (3) , pp. 884-889. 10.1007/s00044-017-2110-8
file

Baldwin, Alex ORCID: https://orcid.org/0000-0002-7126-5220, Tapia, Victor S., Swanton, Tessa, White, Claire S., Beswick, James A., Brough, David and Freeman, Sally 2018. Design, synthesis and evaluation of oxazaborine inhibitors of the NLRP3 inflammasome. ChemMedChem 13 (4) , pp. 312-320. 10.1002/cmdc.201700731
file

Baldwin, Alex ORCID: https://orcid.org/0000-0002-7126-5220, Rivers-Auty, Jack, Daniels, Michael J.D., White, Claire S., Schwalbe, Carl H., Schilling, Tom, Hammadi, Halah, Jaiyong, Panichakorn, Spencer, Nicholas G., England, Hazel, Luheshi, Nadia M., Kadirvel, Manikandan, Lawrence, Catherine B., Rothwell, Nancy J., Harte, Michael K., Bryce, Richard A., Allan, Stuart M., Eder, Claudia, Freeman, Sally and Brough, David 2017. Boron-based inhibitors of the NLRP3 inflammasome. Cell Chemical Biology 24 (11) , pp. 1321-1335. 10.1016/j.chembiol.2017.08.011
file

University of Manchester 2017. Cyclic diarylboron derivatives as NLRP3 inflammasome inhibitors. WO/2017/017469. [Patent].

Daniels, Michael J. D., Rivers-Auty, Jack, Schilling, Tom, Spencer, Nicholas G., Watremez, William, Fasolino, Victoria, Booth, Sophie J., White, Claire S., Baldwin, Alex ORCID: https://orcid.org/0000-0002-7126-5220, Freeman, Sally, Wong, Raymond, Latta, Clare, Yu, Shi, Jackson, Joshua, Fischer, Nicolas, Koziel, Violette, Pillot, Thierry, Bagnall, James, Allan, Stuart M., Paszek, Pawel, Galea, James, Harte, Michael K., Eder, Claudia, Lawrence, Catherine B. and Brough, David 2016. Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models. Nature Communications 7 , 12504. 10.1038/ncomms12504
file

Baldwin, Alex ORCID: https://orcid.org/0000-0002-7126-5220, Brough, David and Freeman, Sally 2015. Inhibiting the inflammasome: a chemical perspective. Journal of Medicinal Chemistry 59 (5) , pp. 1691-1710. 10.1021/acs.jmedchem.5b01091

This list was generated on Sat Mar 8 05:18:26 2025 GMT.


Maintained by Cardiff University Information Services